Article
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
29 May 2007
Abstract excerpt
MRI is the most important paraclinical measure for assessing and monitoring the pathologic changes implicated in the onset and progression of multiple sclerosis (MS). Conventional MRI sequences, such as T1-weighted gadolinium-enhanced and spin-echo T2-weighted imaging, are unable to provide full details about the degree of inflammation and underlying neurodegenerative changes. Newer nonconventional MRI techniques...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
